<DOC>
	<DOCNO>NCT00982579</DOCNO>
	<brief_summary>Objectives : Safety immunogenicity MVA.HIVA vaccine 20-week-old healthy Gambian infant bear HIV-1/2-uninfected mother . Gross impact MVA.HIVA immunogenicity EPI vaccine ( DTwPHib , HepB , PCV-7 OPV ) administer 20 week ( 4 week last EPI vaccine ) , BCG vaccine within first 4 week life .</brief_summary>
	<brief_title>Safety Immunogenicity Study Candidate HIV-1 Vaccine Given Healthy Infants Born HIV-1/2-uninfected Mothers</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant , 19 week age , weight age zscores within 2 standard deviation normal . Have receive standard EPI immunization accord national immunization programme . Written inform consent parent . Mother HIV1/2uninfected . Acute disease time vaccination ( acute disease define presence moderate severe illness without fever ) . All vaccine administer person minor illness diarrhoea , mild upper respiratory tract infection without lowgrade febrile illness , i.e . axillary temperature &lt; 37.5 °C ) . Axillary temperature ≥ 37.5 °C time vaccination . Any clinically significant abnormal find screen biochemistry haematology 19 week . History allergic disease reaction likely exacerbate component vaccine , e.g . egg product . Presence underlying disease compromise diagnosis evaluation response vaccine . Invasive bacterial infection ( pneumonia , meningitis ) . Any ongoing chronic illness require hospital specialist supervision . Administration immunoglobulins and/or blood product within one month precede plan administration vaccine candidate . Any history anaphylaxis reaction vaccination . Research physician 's assessment lack willingness parent participate comply requirement protocol , identification factor felt significantly increase infant 's risk suffer adverse outcome . Likelihood travel away study area . Untreated malaria infection . Any clinical evidence infection .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>HIV preventive vaccine</keyword>
</DOC>